Stay updated on SBRT plus Immunotherapy in Early NSCLC Pre-Surgery Clinical Trial

Sign up to get notified when there's something new on the SBRT plus Immunotherapy in Early NSCLC Pre-Surgery Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT plus Immunotherapy in Early NSCLC Pre-Surgery Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    No significant changes to core trial content were detected; observed updates are limited to formatting and metadata without affecting study arms, eligibility, locations, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T12:48:25.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    3%
    Check dated 2025-10-05T17:31:35.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0 and added a contact number.
    Difference
    0.1%
    Check dated 2025-09-28T10:47:19.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; the Back to Top element was removed. No changes to core content, pricing, stock, or time-slot information.
    Difference
    0.2%
    Check dated 2025-09-14T00:33:54.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.2%
    Check dated 2025-09-06T21:13:55.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new publications related to investigational techniques and therapies. Notably, the term 'pembrolizumab' has been reintroduced, indicating a focus on this therapeutic agent.
    Difference
    5%
    Check dated 2025-08-30T15:38:32.000Z thumbnail image

Stay in the know with updates to SBRT plus Immunotherapy in Early NSCLC Pre-Surgery Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT plus Immunotherapy in Early NSCLC Pre-Surgery Clinical Trial page.